Financhill
Back

GSK PLC Quote, Financials, Valuation and Earnings

GSK PLC Price Quote

$33.61
+0.01 (+0.54%)
(Updated: December 21, 2024 at 5:29 AM ET)

GSK PLC Key Stats

Sell
29
GSK PLC (GSK) is a Sell

Day range:
$33.04 - $33.87
52-week range:
$32.83 - $45.93
Dividend yield:
4.66%
P/E ratio:
11.26
P/S ratio:
1.74
P/B ratio:
3.66%

Volume:
6.8M
Avg. volume:
5.6M
1-year change:
-7.16%
Market cap:
$68.6B
Revenue:
$37.7B
EPS:
$1.54

How Much Does GSK PLC Make?

Data Unavailable

Is GSK PLC Growing As A Company?

Data Unavailable

GSK PLC Stock Price Performance

  • Did GSK PLC Stock Go Up Last Month?
    GSK PLC share price went up by 0.75% last month
  • Did GSK's Share Price Rise Over The Last Year?
    GSK share price fell by -7.16% over the past 1 year

What Is GSK PLC 52-Week High & Low?

  • What Is GSK PLC’s 52-Week High Share Price?
    GSK PLC has traded as high as $45.93 over the past 52 weeks
  • What Is GSK PLC’s 52-Week Low Share Price?
    GSK PLC has traded as low as $32.83 over the past 52 weeks

GSK PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy GSK PLC?

Data Unavailable

Is GSK PLC Cash Flow Positive?

Data Unavailable

GSK PLC Return On Invested Capital

Data Unavailable

GSK PLC Earnings Date & Stock Price

  • What Is GSK PLC's Stock Price Today?
    A single share of GSK can be purchased today for 33.60
  • What Is GSK PLC’s Stock Symbol?
    GSK PLC trades on the nyse under the ticker symbol: GSK
  • When Is GSK PLC’s Next Earnings Date?
    The next quarterly earnings date for GSK PLC is scheduled on February 5, 2025
  • When Is GSK's next ex-dividend date?
    GSK PLC's next ex-dividend date is November 15, 2024
  • How To Buy GSK PLC Stock?
    You can buy GSK PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

GSK PLC Competitors

  • Who Are GSK PLC's Competitors?
    Below is a list of companies who compete with GSK PLC or are related in some way:
    • AstraZeneca PLC (AZN)
    • Merck & Co Inc (MRK)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)
    • Sanofi SA (SNY)

GSK PLC Dividend Yield

Data Unavailable

GSK PLC Analyst Estimates

YoY Growth Past Surprise
EPS: -27.64% 10.97%
Revenue: 1.06% 0.5%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 42.93
Upside from Last Price: 27.77%

Major Shareholders

Data Unavailable